Investing Profile

Roberto De Ponti

InvestorVC
Managing Director and General Partner at 3B FUTURE Health
Photo of Roberto De Ponti, Managing Director at 3B Future Health Ventures (Helsinn Investment Fund)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
6
$12M
CompanyStageDateRound SizeTotal Raised
Kainova Therapeutics
Series BFeb 2026$23M
Series AMay 2022$41M
$70M
Co-investors: Emmanuel Fiessinger (Seventure Partners)
Fore Biotherapeutics
Series DMay 2025$40M
Series DAug 2023$75M
$170M
Co-investors: Matthew Foy (SR One), Michal Silverberg (Novartis Venture Fund), Simeon J. George (SR One), Ran Nussbaum (Pontifax Venture Capital), Chandra Leo (HBM Partners AG)
Geneos Therapeutics
Series AApr 2023$5M
$17M
Co-investors: Sangwoo Lee (Korea Investment Partners)
Roca Therapeutics
SeedSep 2022